Neuberger Berman Group »

Catalyst Pharmaceutical Partners shares owned by Neuberger Berman Group

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Neuberger Berman Group from 13F filings

Historical chart of Neuberger Berman Group investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Neuberger Berman Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Neuberger Berman Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.8M 194k 19.70
2025-06-30 $5.7M 261k 21.70
2025-03-31 $5.0M 205k 24.25

More positions owned by Neuberger Berman Group

Microsoft Corp Common (MSFT)
Nvidia Corp Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Jpmorgan Chase & Co Common (JPM)
Alphabet Inc Class A A Common (GOOGL)
Alphabet Inc-cl C Common (GOOG)
Meta Platforms Inc Class A A Common (META)
Home Depot Common (HD)
Oracle Corp Common (ORCL)
Eli Lilly & Co Common (LLY)
Broadcom Common (AVGO)
Ishares Core S&p Etf Trust Etf-e Etf (IVV)
T Mobile Us Common (TMUS)
Berkshire Hathaway Inc Class B B Common (BRK.B)

View all positions for Neuberger Berman Group

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Vanguard Group
State Street Corporation
Deerfield Management Company
Renaissance Technologies
Fundsmith
Morgan Stanley
Geode Capital Management
American Century Companies
Dimensional Fund Advisors
Royce & Associates
Millennium Management
Charles Schwab Investment Management
Arrowstreet Capital, Limited Partnership
Robeco Investment Management

View all funds holding Catalyst Pharmaceutical Partners